If all eligible patients filled their prescriptions through a $4 generic drug program, the societal savings could amount to nearly $6 billion, according to new U.S. study. It is the first to evaluate the potential national savings from a broad use of the discounted generic medication programs that are available at many retail stores’ pharmacies.